Effect of 30-minutes versus 60-minutes uterine artery occlusion tourniquet time during open myomectomy on levels of anti-mullerian hormone: a randomized clinical study in NAUTH, Nnewi, Nigeria. - Trial PACTR202307527164991
Access comprehensive clinical trial information for PACTR202307527164991 through Pure Global AI's free database. This Not Applicable trial is sponsored by Dr Lambert Chukwu Onyejiaku and is currently Recruiting. The study focuses on Obstetrics and Gynecology.
This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to Pan Africa Clinical Trials Registry data, helping medical device and pharmaceutical companies navigate clinical research efficiently.
Study Focus
procedure
Sponsor & Location
Dr Lambert Chukwu Onyejiaku
Timeline & Enrollment
Not Applicable
Jul 10, 2023
Jan 01, 1900
Summary
Background: Uterine fibroid is the most common of benign gynaecological tumours. One of the traditional methods of reduction of blood loss during open myomectomy is with application of uterine tourniquet. There remains concern to the effect of use of uterine tourniquet on ovarian reserve in women desirous of preserving their ovarian function. Ovarian reserve is the qualitative and quantitative availability of primordial follicles in the ovaries of a reproductive aged woman that can turn into mature follicles with reproductive potentials. Various forms of markers can be used to assess this including the static markers (oestradiol, follicle stimulating hormones, inhibin-B and anti-Mullerian hormone, AMH).Aim and Objectives: To evaluate the effect of uterine artery occlusion and duration of tourniquet time on ovarian reserve during open myomectomy.
ICD-10 Classifications
Data Source
Pan Africa Clinical Trials Registry
PACTR202307527164991
Non-Device Trial